160 related articles for article (PubMed ID: 26622627)
21. Attenuated Salmonella VNP20009 mutant (ΔhtrA) is a promising candidate for bacteria-mediated tumour therapy in hosts with TNFR1 deficiency.
Xu W; Zhou T; Zhou J; Qiang Z; Zhang J; Hua Z
Lett Appl Microbiol; 2018 Jul; 67(1):97-103. PubMed ID: 29698572
[TBL] [Abstract][Full Text] [Related]
22. Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.
Shi L; Yu B; Cai CH; Huang JD
AMB Express; 2016 Dec; 6(1):56. PubMed ID: 27558018
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of YB1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model.
Shi JH; Cui NP; Wang S; Zhao MZ; Wang B; Wang YN; Chen BP
FEBS Open Bio; 2016 Jan; 6(1):33-42. PubMed ID: 27047740
[TBL] [Abstract][Full Text] [Related]
24. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice.
Matsumoto Y; Miwa S; Zhang Y; Zhao M; Yano S; Uehara F; Yamamoto M; Hiroshima Y; Toneri M; Bouvet M; Matsubara H; Tsuchiya H; Hoffman RM
Oncotarget; 2015 May; 6(13):11369-77. PubMed ID: 25957417
[TBL] [Abstract][Full Text] [Related]
26. Systemic administration of attenuated
Wang Y; Chen J; Tang B; Zhang X; Hua ZC
Mol Clin Oncol; 2013 May; 1(3):461-465. PubMed ID: 24649192
[TBL] [Abstract][Full Text] [Related]
27. Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.
Czolk R; Schwarz N; Koch H; Schötterl S; Wuttke TV; Holm PS; Huber SM; Naumann U
Int J Mol Med; 2019 Oct; 44(4):1484-1494. PubMed ID: 31432139
[TBL] [Abstract][Full Text] [Related]
28. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
29. [Gene therapy for tongue carcinoma mediated by oral administration of attenuated Salmonella harboring tip30 and IFN-γ genes in nude mouse model].
Jiang ZM; Yin XM; Yu Y; Miao L; Wei W; Zhou Y; Yin XM; Wu YY
Shanghai Kou Qiang Yi Xue; 2013 Feb; 22(1):13-8. PubMed ID: 23552775
[TBL] [Abstract][Full Text] [Related]
30. High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.
Kawaguchi K; Murakami T; Suetsugu A; Kiyuna T; Igarashi K; Hiroshima Y; Zhao M; Zhang Y; Bouvet M; Clary BM; Unno M; Hoffman RM
Oncotarget; 2017 Mar; 8(12):19065-19073. PubMed ID: 27683127
[TBL] [Abstract][Full Text] [Related]
31. Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.
Kocijancic D; Felgner S; Schauer T; Frahm M; Heise U; Zimmermann K; Erhardt M; Weiss S
Oncotarget; 2017 Jul; 8(30):49988-50001. PubMed ID: 28637010
[TBL] [Abstract][Full Text] [Related]
32. Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.
Liang K; Liu Q; Li P; Luo H; Wang H; Kong Q
Cancer Lett; 2019 Apr; 448():168-181. PubMed ID: 30753837
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy.
Chorobik P; Marcinkiewicz J
Pol Arch Med Wewn; 2011 Dec; 121(12):461-6. PubMed ID: 22129784
[TBL] [Abstract][Full Text] [Related]
34. Primer dosing of S. typhimurium A1-R potentiates tumor-targeting and efficacy in immunocompetent mice.
Tome Y; Zhang Y; Momiyama M; Maehara H; Kanaya F; Tomita K; Tsuchiya H; Bouvet M; Hoffman RM; Zhao M
Anticancer Res; 2013 Jan; 33(1):97-102. PubMed ID: 23267132
[TBL] [Abstract][Full Text] [Related]
35. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
[TBL] [Abstract][Full Text] [Related]
36. Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice.
Zhang Y; Tome Y; Suetsugu A; Zhang L; Zhang N; Hoffman RM; Zhao M
Anticancer Res; 2012 Jul; 32(7):2501-8. PubMed ID: 22753706
[TBL] [Abstract][Full Text] [Related]
37. Strains, Mechanism, and Perspective: Salmonella-Based Cancer Therapy.
Wang CZ; Kazmierczak RA; Eisenstark A
Int J Microbiol; 2016; 2016():5678702. PubMed ID: 27190519
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.
Clairmont C; Lee KC; Pike J; Ittensohn M; Low KB; Pawelek J; Bermudes D; Brecher SM; Margitich D; Turnier J; Li Z; Luo X; King I; Zheng LM
J Infect Dis; 2000 Jun; 181(6):1996-2002. PubMed ID: 10837181
[TBL] [Abstract][Full Text] [Related]
39. Violacein anticancer activity is enhanced under hypoxia.
Hashimi SM; Xu T; Wei MQ
Oncol Rep; 2015 Apr; 33(4):1731-6. PubMed ID: 25652759
[TBL] [Abstract][Full Text] [Related]
40. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.
Chen J; Yang B; Cheng X; Qiao Y; Tang B; Chen G; Wei J; Liu X; Cheng W; Du P; Huang X; Jiang W; Hu Q; Hu Y; Li J; Hua ZC
Cancer Sci; 2012 Feb; 103(2):325-33. PubMed ID: 22054098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
